Onderneming Invivo Therapeutics Holdings Corp Nasdaq
Aandelen
US46186M2098
Geavanceerde medische apparatuur & technologie
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 05-07-17 |
Director of Finance/CFO | 54 | 14-01-19 | |
Heather M. Hamel
LAW | General Counsel | - | 12-07-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 57 | 08-06-16 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 08-11-19 |
C. Merrifield
CHM | Chairman | 73 | 11-11-14 |
Richard Toselli
CEO | Chief Executive Officer | 66 | 05-07-17 |
Director/Board Member | 80 | 01-10-10 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 105 446 | 3 104 797 ( 99,98 %) | 0 | 99,98 % |
Bedrijfsgegevens
Invivo Therapeutics Holdings Corp.
Building 1400 West One Kendall Square
02139, Cambridge
+617 863 5500
http://www.invivotherapeutics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,46% | 218 mld. | |
+7,62% | 184 mld. | |
+13,29% | 135 mld. | |
+0,04% | 62,38 mld. | |
+11,92% | 51,37 mld. | |
+4,81% | 50,9 mld. | |
+1,17% | 40,87 mld. | |
+2,35% | 36,28 mld. | |
+26,28% | 31,88 mld. |